Page 35 - Genetics News Today

We appreciate your time. Im dion lim. For all of us here, thanks so much for inviting us tonight, right here, President Trump on why he suddenly called off the attack on iran. After iran shot down that u. S. Drone, the president says the u. S. Was cocked and loaded. Saying, ten minutes before the strike, i stopped it. Tonight, the president in his own words. What changed his mind. Martha raddatz with late reporting. The massive explosions in philadelphia. The largest refinery on the east coast g...

website, even social posts... in minutes! -how? -a.i. (impressed) ay i like it! who wants to come see the future?! get your business online in minutes with godaddy airo hi, im gina. ive tried so many things to lose weight. none of it worked. i would quit after a few days or a week at the most. golo is not like any of those. with golo and release i not only met my goal ive surpassed it. and im keeping it off. >> ainsley: its 8 a.m. on the east coast, tuesday, june 11, this is "fox and f...

>> thats it for me. thanks for watching. tune in tomorrow where i am speaking with congressman jerry connelly. plus, senior adviser and spokes person for president bidens campaign, adrienne elrod joins us to talk importance of border security to voters ahead of novembers election tomorrow at 6:00 p.m. eastern on msnbc. follow us on social media using the handle, at weekend capehart. listened every episode of our show as a podcast for free. scan the qr code on your screen to follow. b...

One of the challenges we have is the genetic pools we have access to via research need to be broader, they need to reflect the diversity of the population, and particularly it is said that black men are at higher risk of prostate cancer, but we really need to understand the genetics of that, because it could potentially be a subset of black men, so when you are testing people for cancer, and one of the risks is over treatment, we need to be extremely careful to follow through patients to see wha...

Looking at genetics, this test can be much more targeted, hopefully, than the psa test. it is still early days for this test, and they needs more research. we need to test it in a wider pool of people to see if these results stand out. anything that can detect those aggressive prostate cancers, which are about one in five prostate cancers, are really welcome. iii it one in five prostate cancers, are really welcome.— one in five prostate cancers, are really welcome. if it needs more testin: , r...

Actually progressed. so any progress in this area is very welcome. and so by looking at genetics, this test can be much more targeted, hopefully, than the psa test. its still early days, though, for this test, and it needs more research because we need to test it in a wider pool of people to see if these results stand out. but anything that can detect those aggressive prostate cancers, which are about one in five prostate cancers, is really, really welcome. theres a huge amount of work going on ...

Black men are at higher risk of prostate cancer, but we really need to understand the genetics of that because it can actually be potentially a subset of black men. and so when youre testing people for cancer and one of the risks is overtreatment, we need to be extremely careful to follow through patients to see what actually happened to their cancers, to see if they would have caused harm. and thats why we need more research. lets return to the middle east and get more details on that proposed ...

Them more sensitive, thats incredibly helpful. but one of the challenges that we have is that the genetic pools that we have access to through research need to be broader, they need to reflect the diversity of the population. and particularly, its said that black men are at higher risk of prostate cancer, but we really need to understand the genetics of that because it can actually be potentially a subset of black men. and so when youre testing people for cancer and one of the risks is overtreat...

Now, the situation with prostate cancer now is that the current test, known as the psa test, often misses the aggressive cancers and can actually lead to overtreatment of cancers that never would have actually progressed. so any progress in this area is very welcome. and so by looking at genetics, this test can be much more targeted, hopefully, than the psa test. its still early days, though, for this test, and it needs more research because we need to test it in a wider pool of people to see if...

Two copies of APOE4 may be more than just a risk factor for AD; the pair may cause the disease in 15%-20% of cases.